Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹822.55
Market cap: ₹12,946 Cr
Revenue (annual): ₹4,359 Cr
Net profit (annual): ₹255.2 Cr
P/E (TTM): 44.4×Sector 47.3×
Promoter holding: 75.26%+0.00% QoQ
FII holding: 1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Earnings Call 5 Legal & Regulatory 4 Financial Results 3 Adverse Business Impact 3 Results Update 2 Management Change 2 Board Meeting Date 2 Merger & Restructuring 1 Fund Raise 1 Credit Rating 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 May 2026 17:52 IST NSE

Management Change

Akums Drugs & Pharmaceuticals Management Change

Akums Drugs and Pharmaceuticals appointed Mahajan & Aibara LLP as Internal Auditors for twelve months. The firm brings extensive multidisciplinary expertise to the company's internal control systems.

Execution: 12 months

Read the filing ↗

14 May 2026 17:47 IST NSE

Management Change

Akums Drugs & Pharmaceuticals Management Change

Akums Drugs appointed V Jagannathan and announced the cessation of Arvind Srivastava as Senior Management Personnel. These leadership changes are effective from May 14, 2026.

Read the filing ↗